62
Participants
Start Date
June 4, 2020
Primary Completion Date
July 8, 2023
Study Completion Date
September 28, 2023
AB011 Injection
"Stage 1 Single treatment: AB011 Injection with dose escalation of 1mg/kg up to 40mg/kg, as well as dose expansion with recommended dose level from dose escalation.~Stage 2 Combo Treatment: AB011 combine XELOX( GC) or Gem/nab-P (PC) Injection with dose escalation of 10mg/kg up to 30mg/kg, as well as dose expansion with recommended dose level from dose escalation."
Beijing Cancer Hospital, Beijing
Harbin Medical University Cancer Hospital, Harbin
Zhongshan Hospital, Zhongshan University, Shanghai
Shanghai East Hospital, Shanghai
Anhui Provincial Hospital, Hefei
Linyi Cancer Hospital, Linyi
The First Affiliated Hospital, Zhejiang University, Hangzhou
Sir Run Run Shaw Hospital, Hangzhou
Xiangya Hospital Central South University, Changsha
Huaihua Second People's Hospital, Huaihua
Henan Cancer Hospital, Zhengzhou
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
Lead Sponsor
Shanghai East Hospital
OTHER
CARsgen Therapeutics Co., Ltd.
INDUSTRY